CVM GFI #96 (VICH GL13) Effectiveness of Anthelmintics: Specific Recommendations for Ovines-2026/6/23

CVM GFI #97 (VICH GL14) Effectiveness of Anthelmintics: Specific Recommendations for Caprines-2026/6/23

Submitting Clinical Trial Datasets to Evaluate the Impact of Immunogenicity on the Pharmacokinetics of a Drug -2026/6/18

Forms FDA 3542a and FDA 3542: Questions and Answers-2026/6/15

Intent to Exempt Certain Unclassified Medical Devices from Premarket Notification Requirements-2026/6/5

Certain Postapproval Requirements and Resources for ANDAs-2026/6/4

Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities – Questions and Answers-2026/6/3

M15 General Principles for Model-Informed Drug Development-2026/6/3

Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing-2026/6/2

Q8, Q9, and Q10 Questions and Answers (R5) -2026/5/29